NIZORAL DANDRUFF

देश: आयरलैंड

भाषा: अंग्रेज़ी

स्रोत: HPRA (Health Products Regulatory Authority)

सक्रिय संघटक:

KETOCONAZOLE

थमां उपलब्ध:

Johnson & Johnson (Ireland) Limited

ए.टी.सी कोड:

D01AC08

INN (इंटरनेशनल नाम):

KETOCONAZOLE

डोज़:

20 mg/g

फार्मास्यूटिकल फॉर्म:

Shampoo

प्रिस्क्रिप्शन प्रकार:

Product not subject to medical prescription

चिकित्सीय क्षेत्र:

ketoconazole

प्राधिकरण का दर्जा:

Marketed

प्राधिकरण की तारीख:

1999-11-26

उत्पाद विशेषताएं

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Nizoral Dandruff 20mg/g Shampoo
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each gram of shampoo contains 20mg of ketoconazole
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Shampoo
Pink, viscous shampoo
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
In the prevention and treatment of infections in which_ Malassezia_
(previously called_ Pityrosporum_) infection may be a
factor, such as seborrhoea capitis, and seborrhoeic dermatitis of the
body.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Nizoral Shampoo is for use in adults and adolescents aged 12 years and
over.
Seborrhoea capitis
Apply the shampoo to the affected scalp, leave for three minutes, then
rinse.
Seborrhoeic dermatitis
Wash the affected areas with shampoo and leave for 3 to 5 minutes
before rinsing.
Treatment should be repeated twice weekly for 2 to 4 weeks.
For prophylaxis use once, every 1 to 2 weeks.
Method of administration
Cutaneous.
4.3 CONTRAINDICATIONS
Use in patients hypersensitive to any of the ingredients.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_8_
_/_
_0_
_9_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_2_
_1_
_9_
_6_
_5_
_2_
_5_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
In patients who have been on prolonged treatment with topical
corticosteroids, it is recommended that the steroid
therapy be gradually withdrawn over a period of 2 to 3 weeks, while
using